Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Will This Struggling Heart Device Maker Flatline?

Edwards Lifesciences (NYSE: EW  ) investors have had a tough year, to put it mildly. This heart device maker's stock has cratered in 2013 as Wall Street has grown disappointed with the growth of Edwards' flagship product, its Sapien transcatheter heart valve. The Sapien has managed to capitalize on an exclusive position as the sole device of its type on the U.S. market, but that advantage might come to an end soon.

Rival Medtronic (NYSE: MDT  ) , which has dueled with Edwards for sales in Europe's transcatheter heart valve, has pushed up the launch date of its competing CoreValve product from mid-2014 to the first quarter of next year. Meanwhile, fellow cardiac device maker Boston Scientific (NYSE: BSX  ) recently won European regulatory approval for its own heart valve, the Lotus.

With competition baring down from all sides, can Edwards keep up its growth in this market, or will the Sapien's diminishing advantages spell doom for this slumping stock? Find out in the video below, where Fool contributor Dan Carroll tells you all you need to know about Edwards' latest challenges and how they could affect your investments.

Unearthing the best growth opportunity on the market
Edwards hasn't panned out as the growth opportunity that many investors thought it could be. So, which stock on the market could be the new spark for your portfolio? One incredible tech stock is growing twice as fast as Google and Facebook, and more than three times as fast as and Apple. Watch our jaw-dropping investor alert video today to find out why The Motley Fool's chief technology officer is putting $117,238 of his own money on the table, and why he's so confident this will be a huge winner in 2013 and beyond. Just click here to watch!

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2709592, ~/Articles/ArticleHandler.aspx, 9/29/2016 2:54:41 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 5 hours ago Sponsored by:
DOW 18,339.24 110.94 0.61%
S&P 500 2,171.37 11.44 0.53%
NASD 5,318.55 12.84 0.24%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 4:02 PM
BSX $23.75 Up +0.03 +0.13%
Boston Scientific CAPS Rating: ***
EW $120.46 Down -0.76 -0.63%
Edwards Lifescienc… CAPS Rating: ****
MDT $86.74 Up +0.07 +0.08%
Medtronic CAPS Rating: *****